In Brief: Lilly/Centocor ReoPro
Executive Summary
Lilly/Centocor ReoPro: Supplemental applications filed Feb. 18 for use of abciximab in all patients undergoing angioplasty and for stabilizing patients with unstable angina. ReoPro is approved for use in high-risk angioplasty patients...